Study to Evaluate the Efficacy and Safety of PB-201 in Type 2 Diabetic Mellitus Patients With Poor Glycemic Control Via Metformin Hydrochloride Monotherapy
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 546 participants.
Also called NCT05326490
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 546 participants
- Sponsor
- Registry
-
NCT05326490
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT05326490. Randomized; quadruple masking; primary purpose treatment. Start 2022-05-30 (anticipated); primary completion 2024-09-24 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Study to Evaluate the Efficacy and Safety of PB-201 in Type 2 Diabetic Mellitus Patients With Poor Glycemic Control Via Metformin Hydrochloride Monotherapy
- Condition
- Type 2 Diabetes Mellitus
- Intervention (Drug)
- PB-201
- Intervention (Drug)
- PB-201 matched placebo
- Intervention (Drug)
- Metformin hydrochloride
- Lead sponsor
- PegBio Co., Ltd.
Record details
- Record id
cardio:ct-nct05326490- Content hash
e83e1df939738b0d1bfb2e21f5f80d012768fcd68c2e5819e6067b7c5c08ebfa